The Scientist - Home

Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, cell therapy development, and more. 

As scientists and the public alike set their sights on the cosmos, researchers brainstorm plans to keep humans safe in space. 

Tanning beds not only increase melanoma risk but also inflict a molecular toll, causing a spike in DNA mutations within skin cells.

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later in life.

This postdoc studies the structure-function relationships of molecules to enable new reactions and energy-storage strategies.

A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, survival, and hope.

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Developing next-generation liquid biopsies, this postdoc blends spectroscopy and AI to improve cancer detection and prognosis.

The end of the shutdown did not resolve the uncertainty facing US researchers, who continue to navigate delays and budget constraints that slow scientific progress.

Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the development of regulatory T cells.

Sequencing diverse populations revealed over 41,000 transcripts missing in Eurocentric references, exposing ancestry bias that limits insights into global disease risk.

Anxiety and insomnia don’t just affect mood. Researchers found that these conditions can reduce natural killer cell counts, possibly compromising immune strength.